Cargando…
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
National Regulatory Authorities (NRAs) globally are facing the challenge of evaluating pharmaceutical products in a speedy manner, whilst simultaneously ensuring adequate efficacy, safety and quality of approved products. Additionally, common expectations include that the evaluation process is compe...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589776/ https://www.ncbi.nlm.nih.gov/pubmed/36271207 http://dx.doi.org/10.1007/s43441-022-00465-2 |